Muzammil Ali

761 citations
15 papers · 531 indexed · 1 hit paper · h-index 10
Topics
Influenza Virus Research Studies (3 papers)interferon and immune responses (3 papers)Atherosclerosis and Cardiovascular Diseases (3 papers)
Partner nations
United StatesJapanCanada

In The Last Decade

Muzammil Ali

15 papers receiving 508 citations

Hit Papers

Durvalumab plus gemcitabine and cisplatin in advanced bil...20242026202520241020304050

Peers

Muzammil Ali
Comparison fields: 5 of 90
  • Epidemiology 128
  • Immunology 119
  • Molecular Biology 99
  • Surgery 98
  • Nutrition and Dietetics 91
Replace Andrea N. Faris with:
Andrea N. Faris United States
Prakash B Desai India
Yuhong Guo China
Zhonghong Wei China
Shivaraj Gowda India
Yupei Zhang China
Avinash Math India
Prema Gurumurthy India
Muzammil Ali relative to Andrea N. Faris United States Andrea N. Faris's profile →
Citations per field
00.5×3.3×
Andrea N. Faris · 1×
Citations per year

Countries citing papers authored by Muzammil Ali

Since Specialization
Citations

This map shows the geographic impact of Muzammil Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muzammil Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muzammil Ali more than expected).

Fields of papers citing papers by Muzammil Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muzammil Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muzammil Ali. The network helps show where Muzammil Ali may publish in the future.

Co-authorship network of co-authors of Muzammil Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Muzammil Ali. A scholar is included among the top collaborators of Muzammil Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muzammil Ali. Muzammil Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trialbreakdown →
51
2 11
3 34
4 26
5 36
6
Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature.
34
7 77
8 188
9 21
10
Abstract 147: Statins Block Influenza Infection By Down-regulating Rho/rho Kinase Pathway
3
11 1
12 32
13
Redefining the lowest exercise peak oxygen consumption acceptable for lung resection of high risk patients
8
14
Nodus migrans: the case of the migrating knot.
6
15
Cardiac emergencies in the cancer patient.
3

About Muzammil Ali

Muzammil Ali is a scholar working on Immunology, Otorhinolaryngology and Epidemiology, having authored 15 papers that have together received 531 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (3 papers), interferon and immune responses (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). The work is most often cited by research in Complementary and alternative medicine (54 citations), Biochemistry (37 citations) and Nutrition and Dietetics (91 citations). Muzammil Ali has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Mohammad Madjid, Mehran Haidari, S. Ward Casscells, Zhenping Chen, Deborah Vela, Philip R. Wyde, Silvio Litovsky, James T. Willerson, Wei Zhang and Lorraine Frazier. Their work appears in journals such as Circulation, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026